The Lancet Respiratory Medicine in conversation with

By The Lancet GroupMedicine Health & Fitness

The Lancet Respiratory Medicine in conversation with episodes

January 12, 2021 Evaluating deterioration in patients with acute COVID-19
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
9 min
January 05, 2021 Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
16 min
December 18, 2020 COVID-19 and severe influenza
Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
9 min
November 11, 2020 The second wave and homeless populations
Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
8 min
September 25, 2020 Corticosteroids, COPD, asthma and COVID-19
Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
10 min
September 08, 2020 Novel strategies to drive down the global burden of asthma
Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
12 min
August 05, 2020 The pathology of suspected EVALI
Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
13 min
July 17, 2020 Wheezing illness and RSV-LRTI
Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for RSV vaccines.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
6 min
March 16, 2020 Antibiotic use in infancy and asthma incidence
Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
8 min
March 12, 2020 Guidance on the development of prediction models for critical care
David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical care
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
11 min

About The Lancet Respiratory Medicine in conversation with

From the publisher's feed

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio…